Financials
- Market Capitalization 356.06 M
- Employee 161
- Founded 2018
- CEO N/A
- Website www.lyell.com
- Headquarter Delaware, United States
- FIGI BBG00RNXFN14
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-1.11
Relación precio/flujo de caja
9 792.6
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 3101 | LXEO Lexeo Therapeutics, Inc. - Common Stock | 4.63 USD | -2.73% | -8.68% | +11.57% | -2.94% | 379.87 M USD | ||
| 3131 | IPSC Century Therapeutics, Inc. - Common Stock | 2.02 USD | -1.46% | -6.05% | -1.46% | +312.24% | 365.77 M USD | ||
| 3160 | AGEN Agenus Inc. - Common Stock | 7.84 USD | +3.02% | -4.04% | +2.48% | +89.83% | 352.96 M USD | ||
| 3181 | PALI Palisade Bio, Inc. - Common Stock | 1.97 USD | +1.03% | -5.29% | +3.68% | +15.88% | 343.31 M USD |